tradingkey.logo

Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding

ReutersFeb 5, 2026 4:07 PM

- Novo Nordisk NOVOb.CO said on Thursday it would take legal action against Hims & Hers HIMS.N after the online telehealth company said it will begin offering compounded copies of the Danish group's Wegovy pill at an introductory price of $49 per month.

"The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety," the Danish drugmaker said in a statement.

"Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the U.S. gold-standard drug approval framework," it added.

Novo Nordisk said it was the only company that manufactured an FDA-approved Wegovy pill formulated with SNAC technology, which facilitates semaglutide absorption when administered orally.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI